Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title: ERRATUM
Volume: 9 Issue: 1
Export Options
About this article
Cite this article as:
ERRATUM, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2009; 9 (1) . https://dx.doi.org/10.2174/187152209788009814
DOI https://dx.doi.org/10.2174/187152209788009814 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
12
Related Articles
-
Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus
Current Drug Targets An Overview on the Importance of Combining Complementary Analytical Platforms in Metabolomic Research
Current Topics in Medicinal Chemistry Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases
CNS & Neurological Disorders - Drug Targets Peptides as Tight Junction Modulators
Current Pharmaceutical Design Leukocytoclastic Vasculitis Associated with HHV6-A/ciHHV6-A and HHV6-B Coinfection in an Immunocompetent Woman
Endocrine, Metabolic & Immune Disorders - Drug Targets ENaC Modulators and Renal Disease
Current Molecular Pharmacology Gold and Silver Nanoparticles in Bioassay, Cell Visualization and Therapy
Current Clinical Pharmacology Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
Current Molecular Medicine The Application of Fungal Beta-glucans for the Treatment of Colon Cancer
Anti-Cancer Agents in Medicinal Chemistry Pharmacokinetics, Metabolism, Distribution and Permeability of Nanomedicine
Current Drug Metabolism Context-Dependent Regulation of Nrf2/ARE Axis on Vascular Cell Function during Hyperglycemic Condition
Current Diabetes Reviews Pharmacovigilance and the Cardiovascular System: Two Sides to Every Story
Current Drug Safety Non-Classical Therapeutic Approach in the Treatment of Alzheimer's Disease: A Mini Review
Letters in Drug Design & Discovery Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Ischemic Brain Injury
Recent Patents on CNS Drug Discovery (Discontinued) PREFACE
Endocrine, Metabolic & Immune Disorders - Drug Targets Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels
Current Neuropharmacology Epigenetics Changes in the RA Synovium
Current Rheumatology Reviews Current Status and Use of Resources of Lysosomal Storage Diseases: Analysis of a Spanish Claims Database
Endocrine, Metabolic & Immune Disorders - Drug Targets Four Major Factors Regulate Phosphatidylinositol 3-kinase Signaling Pathway in Cancers Induced by Infection of Human Papillomaviruses
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Stem Cell Research & Therapy